ClinicalTrials HQ

A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

Active, not recruiting · NCT06443684 · Registry updated 2026-06-17
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLCNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingNot stated2026-06-17NCT06443684

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Shanghai Chest Hospital116

14 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Affiliated Cancer Hospital of Harbin Medical UniversityHarbinChina4
First Affiliated Hospital of Xiamen UniversityXiamenChina3
Hunan Cancer HospitalChangshaChina87
Qilu Hospital of Shandong UniversityJinanChina25
Shandong Provincial HospitalJinanChina24
Shanghai Chest HospitalShanghaiChina31
Shanxi Cancer HospitalTaiyuanChina25
The First Affiliated Hospital of Guangzhou Medical UniversityGuangzhouChina34
The First Affiliated Hospital of USTC / Anhui Provincial HospitalHefeiChina1
The First Affiliated Hospital of Xi 'an Jiaotong UniversityXi’anChina2
The First Affiliated Hospital of Zhejiang UniversityHangzhouChina4
The First Affiliated Hospital of Zhengzhou UniversityZhengzhouChina56
Zhejiang Cancer HospitalHangzhouChina84
Zhongshan Hospital Affiliated to Fudan UniversityShanghaiChina10